Actinium Pharmaceuticals (STU:7AY1) Ending Cash Position : €69.93 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Actinium Pharmaceuticals Ending Cash Position?

Actinium Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 was €69.93 Mil.

Actinium Pharmaceuticals's quarterly Ending Cash Position declined from Jun. 2024 (€80.22 Mil) to Sep. 2024 (€71.16 Mil) and declined from Sep. 2024 (€71.16 Mil) to Dec. 2024 (€69.93 Mil).

Actinium Pharmaceuticals's annual Ending Cash Position declined from Dec. 2022 (€103.47 Mil) to Dec. 2023 (€70.60 Mil) and declined from Dec. 2023 (€70.60 Mil) to Dec. 2024 (€69.93 Mil).

Actinium Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Actinium Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinium Pharmaceuticals Ending Cash Position Chart

Actinium Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

52.61

69.23

103.47

70.60

69.93

Actinium Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															70.60	77.62	80.22	71.16	69.93

Actinium Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Actinium Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	73.526	+	-3.593
	=	69.93

Actinium Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	75.428	+	-5.495
	=	69.93

Actinium Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Actinium Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinium Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinium Pharmaceuticals Inc (STU:7AY1) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

ATNM:USA 7AY1:Germany

Address

100 Park Avenue, 23rd Floor, New York, NY, USA, 10017

Website

https://www.actiniumpharma.com

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Actinium Pharmaceuticals Headlines

No Headlines